CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland
This publication has 62 references indexed in Scilit:
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosisEMBO Molecular Medicine, 2012
- A Validated Regulatory Network for Th17 Cell SpecificationCell, 2012
- IL-17 signaling in host defense against Candida albicansImmunologic Research, 2011
- Transcription factor IRF8 directs a silencing programme for TH17 cell differentiationNature Communications, 2011
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activityNature, 2011
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapyOncogene, 2011
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and HomeostasisImmunity, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsProceedings of the National Academy of Sciences, 2006